PAVmed Capital Expenditures (CapEx) Growth & History (PAVM)
PAVmed's capital expenditures (capex) was $31,000 for fiscal 2025.
View full PAVmed company overviewPAVmed annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $31,000 | −$24,000 | −43.64% |
| 2024 | 2024-12-31 | $55,000 | −$187,000 | −77.27% |
| 2023 | 2023-12-31 | $242,000 | −$1.3M | −84.29% |
| 2022 | 2022-12-31 | $1.5M | $71,000 | +4.83% |
| 2021 | 2021-12-31 | $1.5M | $1.4M | +2570.91% |
| 2020 | 2020-12-31 | $55,000 | $28,000 | +103.70% |
| 2019 | 2019-12-31 | $27,000 | $391 | +1.47% |
| 2018 | 2018-12-31 | $26,609 | $21,308 | +401.96% |
| 2017 | 2017-12-31 | $5,301 | −$16,492 | −75.68% |
| 2016 | 2016-12-31 | $21,793 | — | — |
PAVmed quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13,000 | $5,000 | +62.50% |
| Q1 2026 | 2026-03-31 | $22,000 | $16,000 | +266.67% |
| Q4 2025 | 2025-12-31 | $14,000 | $10,000 | +250.00% |
| Q3 2025 | 2025-09-30 | $3,000 | −$3,000 | −50.00% |
| Q2 2025 | 2025-06-30 | $8,000 | $5,000 | +166.67% |
| Q1 2025 | 2025-03-31 | $6,000 | −$36,000 | −85.71% |
| Q4 2024 | 2024-12-31 | $4,000 | −$179,000 | −97.81% |
| Q3 2024 | 2024-09-30 | $6,000 | −$12,000 | −66.67% |
| Q2 2024 | 2024-06-30 | $3,000 | −$12,000 | −80.00% |
| Q1 2024 | 2024-03-31 | $42,000 | $16,000 | +61.54% |
| Q4 2023 | 2023-12-31 | $183,000 | −$115,000 | −38.59% |
| Q3 2023 | 2023-09-30 | $18,000 | −$298,000 | −94.30% |
| Q2 2023 | 2023-06-30 | $15,000 | −$337,000 | −95.74% |
| Q1 2023 | 2023-03-31 | $26,000 | −$548,000 | −95.47% |
| Q4 2022 | 2022-12-31 | $298,000 | −$979,000 | −76.66% |
| Q3 2022 | 2022-09-30 | $316,000 | $281,000 | +802.86% |
| Q2 2022 | 2022-06-30 | $352,000 | $231,000 | +190.91% |
| Q1 2022 | 2022-03-31 | $574,000 | $538,000 | +1494.44% |
| Q4 2021 | 2021-12-31 | $1.3M | $1.3M | +15862.50% |
| Q3 2021 | 2021-09-30 | $35,000 | $32,000 | +1066.67% |
| Q2 2021 | 2021-06-30 | $121,000 | $79,000 | +188.10% |
| Q1 2021 | 2021-03-31 | $36,000 | $34,000 | +1700.00% |
| Q4 2020 | 2020-12-31 | $8,000 | $6,000 | +300.00% |
| Q3 2020 | 2020-09-30 | $3,000 | $3,000 | — |
| Q2 2020 | 2020-06-30 | $42,000 | $20,000 | +90.91% |
| Q1 2020 | 2020-03-31 | $2,000 | −$1,000 | −33.33% |
| Q4 2019 | 2019-12-31 | $2,000 | — | — |
| Q3 2019 | 2019-09-30 | $0 | — | — |
| Q2 2019 | 2019-06-30 | $22,000 | — | — |
| Q1 2019 | 2019-03-31 | $3,000 | — | — |
| Q4 2017 | 2017-12-31 | $0 | $0 | — |
| Q3 2017 | 2017-09-30 | $0 | −$7,350 | — |
| Q2 2017 | 2017-06-30 | $0 | −$1,915 | — |
| Q1 2017 | 2017-03-31 | $5,301 | −$7,227 | −57.69% |
| Q4 2016 | 2016-12-31 | $0 | — | — |
| Q3 2016 | 2016-09-30 | $7,350 | — | — |
| Q2 2016 | 2016-06-30 | $1,915 | — | — |
| Q1 2016 | 2016-03-31 | $12,528 | — | — |
PAVmed capital expenditures (capex) trends
Over the last five fiscal years, PAVmed's capital expenditures (capex) decreased from $55,000 to $31,000, a change of −$24,000. The latest reported quarter, Q2 2026, shows $13,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PAVmed source filings ↗